In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Enzon spins off biotech business into a new company; ends plan

Executive Summary

Enzon Pharmaceuticals has decided to spin off its biotechnology business as a new company, which will be funded with an initial $150mm cash infusion by Enzon.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • Spin-Off

Related Companies

Advertisement
UsernamePublicRestriction

Register